Kerry M. Clem
Chief Commercial Officer · OS Therapies Inc
Individual
- 2026
- Oct 31, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Kerry M. Clem's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- Robert M. Williams Jr. - $268.34M in AVAH purchases and sales in the last 12 months
- Paul R. Vigano - $268.34M in AVAH purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kerry M. Clem?
Kerry M. Clem is a corporate insider, tracked as Chief Commercial Officer of OS Therapies Inc (OSTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kerry M. Clem submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.